The agreement, which begins in November, gives Sophysa exclusive distribution rights to sell Tissuemed’s dural sealant for use in neuro- and spinal surgery. TissuePatchDural is an ultra-thin adhesive film, which adheres to the body’s internal tissues to prevent the leakage of Cerebrospinal Fluid encountered in surgery.
Speaking about the partnership, Tissuemed’s CEO David Mandley, said: “France is an important market for Tissuemed and I am pleased to have secured Sophysa to distribute TissuePatchDural™. Sophysa are at the forefront of neurosurgery as a manufacturer and distributor of high quality medical devices and Tissuemed are looking forward to working with their highly experienced team to promote TissuePatchDural in France”.
Philippe Nègre, Sophysa’s Managing Director commented: “We are pleased to add TissuePatchDural™ to our portfolio of Neurosurgery products. It reinforces Sophysa’s position as a leading manufacturer and distributor in France and brings innovative solutions to both physicians and patients”.
Sophysa has formally launched TissuePatchDural at the of French-Speaking Society of Neurosurgeons (SNCLF) annual meeting in Paris, 26-28th November 2012 and it has raised considerable interest among the Neurosurgery community.